Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production Exclusive Global Agreement to Transform Surterra’s Ability to Produce Specific Cannabinoids to Meet...

Exclusive Interview with Hyasynth Co-Founder and CEO Kevin Chen Right now, traditional agricultural practices are the main production method of natural cannabinoids. It takes months to create a final...

Exclusive Interview with Cellibre Founder and CEO Ben Chiarelli Cannabinoid biosynthesis is an emerging technology that holds the promise of producing THC, CBD, and other cannabinoids at a fraction...

This is a copy of the April 21st edition of our weekly Newsletter, which we have been publishing since October 2015. Happy Easter Friends! This is one of the...